NCT00757705 - An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia | Biotech Hunter

Enrollment

299

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Schizophrenia

Interventions

DRUG

Paliperidone ER

Participants will receive paliperidone ER tablet in dose range of 3 to12 milligram (mg) per day orally once daily for 24 weeks as per Investigator's discretion based on the individual participant's clinical response to and tolerability of the study drug.